Navigation Links
Stemline Therapeutics Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association of Cancer Research (AACR)
Date:4/18/2012

developed by Stemline as SL-701, demonstrated both immunological and clinical activity in children with malignant glioma.

In the adult study, conducted at the University of Pittsburgh and other centers, adult patients with low-grade glioma (LGG) were treated with the Pitt vaccine via direct subcutaneous injection every three weeks for eight courses. Twenty-four HLA-A2-positive patients were enrolled, including 13 with newly diagnosed high-risk LGG without prior radiotherapy, one with newly diagnosed high-risk LGG with prior radiotherapy, and 10 with recurrent LGG. Side effects were minimal with one grade 3 fever. Sustained and specific immune responses, as assessed by ELISPOT assays, were observed in the majority of evaluable patients. The research team on the adult study led by Dr. Hideho Okada at Pitt, reported that, although a thorough evaluation of progression-free survival would require a longer observation period, among 17 patients who completed eight courses, 10 had stable disease. The team concluded that the Pitt vaccine, now being developed by Stemline as SL-701, was well tolerated and demonstrated immune responses in high risk adult patients with LGG.

About Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates are SL-401 and SL-701, both of which have demonstrated single agent clinical activity in Phase I/II studies of advanced cancer patients. In a multicenter Phase I/II trial in patients with advanced acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS), SL-401 demonstrated single agent activity, including durable complete responses (CRs), and an overall survival (OS) improvement relative to historical data in the most heavily pretreated AML patients. In addition, SL-401 was well-tolerated and was not toxic to the bone marrow. S
'/>"/>

SOURCE Stemline Therapeutics, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Stemline Therapeutics Appoints Kevin Buchi, Former CEO of Cephalon, to Its Board of Directors
2. Stemline Therapeutics, Inc. Names Eric K. Rowinsky, M.D. Chief Medical Officer and Head of Research and Development
3. Stemline Therapeutics Expands Clinical Oncology Program Directed at Cancer Stem Cells With Addition of M.D. Anderson Cancer Center
4. Nile Therapeutics, Inc. Completes $1.34 Million Registered Direct Offering
5. Nile Therapeutics, Inc. to Raise $1.4 Million in Registered Direct Offering
6. Amsterdam Molecular Therapeutics Announces Results of Extraordinary General Meeting
7. Particle Sciences and Pernix Therapeutics Enter into an Agreement to Develop a Pediatric Dermatology Product
8. Tarsa Therapeutics Signs Commercial Supply Agreement for its Ostora™ Oral Calcitonin Product With QS Pharma
9. Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
10. Halo Therapeutics Reports Favorable Independent Review of Lead Drug Candidate HT-100
11. Echo Therapeutics, Inc. Announces 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... 30, 2014 Extensiv ... Aufbau von Kuhmilchverträglichkeit     Kuhmilchproteinallergie (KMPA) ... Säuglingen und Kleinkindern. Der bisher übliche Umgang ... der Babys bzw. deren stillenden Mütter Milchproteine ... sich bei einer beträchtlichen Anzahl von Kindern ...
(Date:10/30/2014)... 30, 2014 Today, DripDrop, the first ... it was awarded a two-year contract, effective Sept. ... that serves the more than 100,000 members and ... and Provista.  DripDrop also received ... member hospitals who attended the recent Novation 2014 ...
(Date:10/30/2014)... Oct. 29, 2014 The global newborn ... test type, technology, product, and geography. The mass ... growth rate in the newborn screening market by ... is attributed to various nations opting for expanded ... instrument used for expanded newborn screening. Furthermore, various ...
Breaking Medicine Technology:Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 2DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 3DripDrop Partners With Novation To Help Hospitals Address I.V. Saline Solution Shortages; ORS Product Used For Ebola Outbreak 4NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 2NewBorn Screening Market by Test Type, Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019 3
... latest developments in molecular diagnostics, personalized medicine, and genetics ... pathologists gather at the Gaylord Texan on September 11 ... College of American Pathologists (CAP). CAP ... in digital imaging related to laboratory medicine with a ...
... 2011 Leatt Corporation, a Nevada corporation (OTC MARKETS: ... Neck Brace System designed to help prevent potentially devastating ... well as other products, today announced that the U.S. ... Commerce issued a patent for the Leatt Neck Brace ...
Cached Medicine Technology:Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens 2Pathologists Gather to Focus on Advances in Molecular Testing, Digital Imaging, and Biospecimens 3U.S. Patent for Leatt Neck Brace System Issued 2
(Date:10/30/2014)... and her research group at the DFG Research Center ... the TU Dresden (CRTD) demonstrated for the first time ... cord in three dimensions from mouse embryonic stem cells. ... interneurons along the dorsal/ventral axis was observed., This study ... " Stem Cell Reports " on 30.10.2014 ., For ...
(Date:10/30/2014)... 30, 2014 Don Allred Insurance, a ... insurance plans for North Carolina residents, is excited to ... Burlington’s Holly Hill Mall. The new branch has been ... helping customers through all facets of the insurance selection ... Insurance spokesman Scott Allred couldn’t be happier with the ...
(Date:10/30/2014)... New Haven, CT (PRWEB) October 30, 2014 ... product categories are raising questions about the impact of ... as the marketing method most likely to influence a ... online research poll of 525 consumers conducted by radio ... in four product categories, isolating the results of respondents ...
(Date:10/30/2014)... 30, 2014 Dr. Joseph Furlin MD, a ... for his practices; OB GYN in Melrose Park, IL ... This website contains important information about each of the care ... downloadable patient forms in English and Spanish. The navigation ... pages on the website provide Dr. Furlin’s patients with important ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 The human ... be more vigorously exercised to help maintain better mental ... the book ‘Dementia Express: Lose Your Memory in 100 ... counterintuitive reasoning and sometimes conflicting attitudes to help keep ... the mind, a reader must decipher the hidden logic ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Dr. Joseph Furlin Launches New Website with Information about Care Services 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2
... SOUTH SAN FRANCISCO, Calif., July 29 Poniard ... focused on innovative oncology therapies, today announced that Jerry McMahon, ... a corporate overview, including a discussion about the clinical development ... upcoming investor conferences: , , , ...
... CDC recommendations loom, new study confirms this group at great ... officials meet Wednesday to decide who should get priority for ... the virus poses to pregnant women should vault that group ... panel convened by the U.S. Centers for Disease Control and ...
... , , , ... Inc., (EHG), a provider of enhanced connectivity, streamlined technology and ... industry, today announced significant additions to its base of payer ... company implemented its industry-leading EDI (electronic data interchange) based claims ...
... , ALISO VIEJO, Calif., July 29 ... that it has signed a definitive Sale and Purchase Agreement ... located in Mexico for approximately one times sales. Tecnofarma ... million in annual sales primarily to the government and private ...
... , , SAN DIEGO, July 29 ... enriched text communication solutions that can reach over 3.5 billion mobile phones ... of distinguished healthcare industry leaders. , , Key ... The mission of the 7-member advisory board is to provide Globaltel Media,s ...
... , , SCOTTSDALE, Ariz., ... leading provider of interoperable workflow solutions that advance the quality and safety ... Rural Health Information Exchange (LARHIX), was awarded "2009 IT Project of the ... information technology magazine. , , A feature ...
Cached Medicine News:Health News:Poniard Pharmaceuticals to Present at Two Upcoming Investor Conferences in August 2Health News:Prioritize Pregnant Women to Get Swine Flu Shot, Experts Say 2Health News:Prioritize Pregnant Women to Get Swine Flu Shot, Experts Say 3Health News:Prioritize Pregnant Women to Get Swine Flu Shot, Experts Say 4Health News:EDI Health Group Continues to Drive Growth of EDI Processing Services in the Dental Healthcare Industry Through Addition of 25 New Connections in the First Half of 2009 2Health News:EDI Health Group Continues to Drive Growth of EDI Processing Services in the Dental Healthcare Industry Through Addition of 25 New Connections in the First Half of 2009 3Health News:EDI Health Group Continues to Drive Growth of EDI Processing Services in the Dental Healthcare Industry Through Addition of 25 New Connections in the First Half of 2009 4Health News:Valeant to Acquire Tecnofarma, A Mexican Generic Company 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 2Health News:Globaltel Media Appoints Leading Healthcare Industry Veterans to Advisory Board 3Health News:Top Healthcare Magazine Awards Carefx Client '2009 IT Project of the Year' 2Health News:Top Healthcare Magazine Awards Carefx Client '2009 IT Project of the Year' 3
The Sonic WAVE™is the first market-ready Alternative to Ultrasound...
... series consists of six analyzer models providing a ... Measured tests include pH, PCO 2 , PO ... potassium, ionized calcium, chloride, glucose, and lactate. Test ... Its space saving design provides the smallest footprint ...
... compact Sleepscan Traveler provides the ultimate flexibility ... PSG data in the home, a patient ... sleep studies utilize the same powerful Sleepscan ... Sleepscan Traveler studies take full advantage of ...
... Kohden developed the world's first ... was completely AC powered in ... developed a number of standard ... measuring systems, such as a ...
Medicine Products: